92 related articles for article (PubMed ID: 15010405)
1. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients.
Van der Linden PJ; De Hert SG; Daper A; Trenchant A; Schmartz D; Defrance P; Kimbimbi P
Can J Anaesth; 2004 Mar; 51(3):236-41. PubMed ID: 15010405
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
[TBL] [Abstract][Full Text] [Related]
3. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
4. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients.
Haisch G; Boldt J; Krebs C; Suttner S; Lehmann A; Isgro F
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):316-21. PubMed ID: 11426361
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
6. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
7. [Effect of hydroxyethyl starch 130/0.4 on S100B protein level and cerebral oxygen metabolism in open cardiac surgery under cardiopulmonary bypass].
Pi ZB; Tan GX; Wang JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1908-11. PubMed ID: 17923015
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
[TBL] [Abstract][Full Text] [Related]
9. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
10. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
[TBL] [Abstract][Full Text] [Related]
11. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass.
Boldt J; Lehmann A; Römpert R; Haisch G; Isgro F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):264-8. PubMed ID: 10890478
[TBL] [Abstract][Full Text] [Related]
12. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution.
Haas T; Fries D; Holz C; Innerhofer P; Streif W; Klingler A; Hanke A; Velik-Salchner C
Anesth Analg; 2008 Apr; 106(4):1078-86, table of contents. PubMed ID: 18349176
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms.
Jin SL; Yu BW
Clin Appl Thromb Hemost; 2010 Feb; 16(1):91-8. PubMed ID: 19825916
[TBL] [Abstract][Full Text] [Related]
14. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin.
Mukhtar A; Aboulfetouh F; Obayah G; Salah M; Emam M; Khater Y; Akram R; Hoballah A; Bahaa M; Elmeteini M; Hamza A
Anesth Analg; 2009 Sep; 109(3):924-30. PubMed ID: 19690268
[TBL] [Abstract][Full Text] [Related]
15. [Volume replacement solutions--pharmacology and clinical use].
Adams HA; Piepenbrock S; Hempelmann G
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jan; 33(1):2-17. PubMed ID: 9530478
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of 5% human albumin and 6% 200/0.5 HES as exclusive colloid components in large surgical interventions].
Vogt N; Bothner U; Georgieff M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 May; 29(3):150-6. PubMed ID: 7519062
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery.
Mahmood A; Gosling P; Vohra RK
Br J Surg; 2007 Apr; 94(4):427-33. PubMed ID: 17380548
[TBL] [Abstract][Full Text] [Related]
19. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]